Antithrombotic treatment in atrial fibrillation.
作者信息
Kalra L, Lip G Y H
机构信息
Cardiovascular Division, King's College London School of Medicine, London, UK.
出版信息
Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.
Abstract
摘要
相似文献
1
Antithrombotic treatment in atrial fibrillation.心房颤动的抗栓治疗
Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.
2
Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.心房颤动的卒中风险评估：基于医院的卒中风险评估和干预计划。
J Clin Pharm Ther. 2011 Feb;36(1):71-9. doi: 10.1111/j.1365-2710.2009.01156.x.
3
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].[心房颤动的抗栓治疗。新推荐及治疗选择的背景]
Lakartidningen. 2008;105(37):2478-80.
4
New anticoagulants for atrial fibrillation.用于心房颤动的新型抗凝剂。
J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee.
5
Atrial fibrillation: stroke prevention in older adults.心房颤动：老年人的卒中预防。
Clin Geriatr Med. 2012 Nov;28(4):617-34. doi: 10.1016/j.cger.2012.08.003.
6
Antithrombotic therapies for stroke prevention in atrial fibrillation.用于心房颤动中风预防的抗栓治疗。
Adv Neurol. 2003;92:249-56.
7
Stroke prevention in atrial fibrillation.心房颤动的卒中预防
Cardiovasc Drugs Ther. 2011 Dec;25(6):561-70. doi: 10.1007/s10557-011-6334-4.
8
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].[心房颤动抗栓治疗指南：意大利止血与血栓形成学会的观点]
Haematologica. 2001 Sep;86(9 Suppl):12-3.
9
Stroke prevention in atrial fibrillation patients.心房颤动患者的卒中预防。
Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819.
10
Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.保护大脑和心脏：非瓣膜性心房颤动的抗血栓治疗。
Angiology. 2014 May;65(5):372-8. doi: 10.1177/0003319713486014. Epub 2013 Apr 25.
引用本文的文献
1
Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.心房颤动与高血压：机制、流行病学及治疗的相似之处
Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):228-34. doi: 10.14797/mdcj-11-4-228.
2
Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutter.心房颤动或心房扑动所致心源性栓塞性卒中后抗栓治疗的分析
Hosp Pharm. 2013 Feb;48(2):127-33. doi: 10.1310/hpj4802-127.
3
Clinical use of aspirin in treatment and prevention of cardiovascular disease.阿司匹林在心血管疾病治疗和预防中的临床应用。
Thrombosis. 2012;2012:245037. doi: 10.1155/2012/245037. Epub 2011 Nov 24.
4
Antithrombotic medication for cardioembolic stroke prevention.用于预防心源性栓塞性卒中的抗血栓药物。
Stroke Res Treat. 2011;2011:607852. doi: 10.4061/2011/607852. Epub 2011 Jun 22.
5
Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.心力衰竭或急性心肌梗死伴左心室功能障碍患者心房颤动的发生率：一项队列研究。
BMC Cardiovasc Disord. 2011 May 14;11:19. doi: 10.1186/1471-2261-11-19.
6
Stroke prevention in the high-risk atrial fibrillation patient: Medical management.高危房颤患者的卒中预防：医学管理。
Curr Cardiol Rep. 2011 Feb;13(1):9-17. doi: 10.1007/s11886-010-0148-z.
本文引用的文献
1
A differential effect of aspirin on prevention of stroke in atrial fibrillation.阿司匹林对心房颤动患者预防中风的差异效应。
J Stroke Cerebrovasc Dis. 1993;3(3):181-8. doi: 10.1016/S1052-3057(10)80159-4. Epub 2010 Jun 9.
2
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.经皮冠状动脉介入治疗的心房颤动患者的抗凝和抗血小板治疗应用：达成共识及制定管理指南的必要性
Chest. 2006 Dec;130(6):1823-7. doi: 10.1378/chest.130.6.1823.
3
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema.
Chest. 2006 Nov;130(5):1296-9. doi: 10.1378/chest.130.5.1296.
4
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.血浆血管性血友病因子水平在心房颤动患者风险分层临床因素中的附加作用。
Stroke. 2006 Sep;37(9):2294-300. doi: 10.1161/01.STR.0000236840.00467.84. Epub 2006 Aug 3.
5
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.英国初级医疗中确诊房颤的患病率趋势、抗凝治疗情况及其治疗的预测因素
Heart. 2006 Aug;92(8):1064-70. doi: 10.1136/hrt.2005.069492. Epub 2005 Dec 30.
6
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.患有心房颤动且中风风险高的住院患者未得到充分的抗凝治疗。
J Am Coll Cardiol. 2005 Nov 1;46(9):1729-36. doi: 10.1016/j.jacc.2005.06.077. Epub 2005 Oct 10.
7
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.非瓣膜性心房颤动且无既往卒中或短暂性脑缺血发作史患者预防卒中的抗血小板治疗。
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD001925. doi: 10.1002/14651858.CD001925.pub2.
8
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.非瓣膜性心房颤动患者使用阿司匹林、华法林和希美加群预防卒中：一项系统评价和荟萃分析
Thromb Res. 2006;118(3):321-33. doi: 10.1016/j.thromres.2005.08.007. Epub 2005 Sep 29.
9
Antithrombotic treatment in atrial fibrillation.心房颤动的抗栓治疗
Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13.
10
Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.无症状性心房颤动：来自心律管理心房颤动随访调查（AFFIRM）研究的人口统计学特征及预后信息。
Am Heart J. 2005 Apr;149(4):657-63. doi: 10.1016/j.ahj.2004.06.032.
Zotero 插件